These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26051303)

  • 1. Fetal endocrine therapy for congenital adrenal hyperplasia should not be done.
    Miller WL
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):469-83. PubMed ID: 26051303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits.
    Miller WL; Witchel SF
    Am J Obstet Gynecol; 2013 May; 208(5):354-9. PubMed ID: 23123167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone.
    Hirvikoski T; Nordenström A; Lindholm T; Lindblad F; Ritzén EM; Wedell A; Lajic S
    J Clin Endocrinol Metab; 2007 Feb; 92(2):542-8. PubMed ID: 17148562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing female virilisation in congenital adrenal hyperplasia: The controversial role of antenatal dexamethasone.
    Heland S; Hewitt JK; McGillivray G; Walker SP
    Aust N Z J Obstet Gynaecol; 2016 Jun; 56(3):225-32. PubMed ID: 26661642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone treatment of congenital adrenal hyperplasia in utero: an experimental therapy of unproven safety.
    Miller WL
    J Urol; 1999 Aug; 162(2):537-40. PubMed ID: 10411085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speaking of accuracy.
    Frader J
    Am J Bioeth; 2010 Sep; 10(9):52. PubMed ID: 20818562
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect on the fetal pituitary-adrenal axis of dexamethasone administration early in the second trimester of pregnancy.
    Mesogitis S; Daskalakis G; Papapetrou P; Mavroudis K; Papandroulaki F; Papantoniou N; Antsaklis A
    J Matern Fetal Neonatal Med; 2011 Jan; 24(1):109-12. PubMed ID: 20528220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia.
    Cerame BI; Newfield RS; Pascoe L; Curnow KM; Nimkarn S; Roe TF; New MI; Wilson RC
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3129-34. PubMed ID: 10487675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The view from the inside: more confusion (and coziness) than consent.
    Green J
    Am J Bioeth; 2010 Sep; 10(9):60-1. PubMed ID: 20818566
    [No Abstract]   [Full Text] [Related]  

  • 10. The intellectual and moral integrity of bioethics: response to commentaries on "A case study in unethical transgressive bioethics: 'Letter of concern from bioethicists' about the prenatal administration of dexamethasone".
    McCullough LB; Chervenak FA; Brent RL; Hippen B
    Am J Bioeth; 2010 Sep; 10(9):W3-5. PubMed ID: 20818546
    [No Abstract]   [Full Text] [Related]  

  • 11. Prenatal treatment of congenital adrenal hyperplasia: report of a new case.
    Loeuille GA; David M; Forest MG
    Eur J Pediatr; 1990 Jan; 149(4):237-40. PubMed ID: 2406146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital adrenal hyperplasia: do the benefits of prenatal treatment defeat the risks?
    Vos AA; Bruinse HW
    Obstet Gynecol Surv; 2010 Mar; 65(3):196-205. PubMed ID: 20214835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia.
    Pang S; Clark AT; Freeman LC; Dolan LM; Immken L; Mueller OT; Stiff D; Shulman DI
    J Clin Endocrinol Metab; 1992 Jul; 75(1):249-53. PubMed ID: 1619017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal treatment of congenital adrenal hyperplasia: author differs with technical report.
    New MI
    Pediatrics; 2001 Apr; 107(4):804. PubMed ID: 11379427
    [No Abstract]   [Full Text] [Related]  

  • 15. Prenatal treatment of congenital adrenal hyperplasia.
    Lancet; 1990 Mar; 335(8688):510-1. PubMed ID: 1968533
    [No Abstract]   [Full Text] [Related]  

  • 16. How safe is long-term prenatal glucocorticoid treatment?
    Seckl JR; Miller WL
    JAMA; 1997 Apr; 277(13):1077-9. PubMed ID: 9091698
    [No Abstract]   [Full Text] [Related]  

  • 17. Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Pang SY; Pollack MS; Marshall RN; Immken L
    N Engl J Med; 1990 Jan; 322(2):111-5. PubMed ID: 2403652
    [No Abstract]   [Full Text] [Related]  

  • 18. Vindication of prenatal diagnosis and treatment of congenital adrenal hyperplasia with low-dose dexamethasone.
    New MI
    Am J Bioeth; 2010 Dec; 10(12):67-8. PubMed ID: 21161854
    [No Abstract]   [Full Text] [Related]  

  • 19. New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002-2011).
    Tardy-Guidollet V; Menassa R; Costa JM; David M; Bouvattier-Morel C; Baumann C; Houang M; Lorenzini F; Philip N; Odent S; Guichet A; Morel Y
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1180-8. PubMed ID: 24471566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 9 treated pregnancies].
    Nivelon JL; Chouchane M; Forest MG; Morel Y; Huet F; Nivelon-Chevallier A; François C
    Ann Pediatr (Paris); 1993 Sep; 40(7):421-5. PubMed ID: 7902059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.